These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 20638280)
1. Refinement of the pharmacophore of 3,4-dihydroquinazoline-2(1H)-thiones for their anti-melanogenesis activity. Thanigaimalai P; Sharma VK; Lee KC; Yun CY; Kim Y; Jung SH Bioorg Med Chem Lett; 2010 Aug; 20(16):4771-3. PubMed ID: 20638280 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of novel tetrahydropyrimidine-2(1H)-thiones on melanogenesis. Thanigaimalai P; Lee KC; Bang SC; Lee JH; Yun CY; Roh E; Hwang BY; Kim Y; Jung SH Bioorg Med Chem; 2010 Feb; 18(3):1135-42. PubMed ID: 20044259 [TBL] [Abstract][Full Text] [Related]
3. Novel benzo[d]imidazole-2(3H)-thiones as potent inhibitors of the alpha-melanocyte stimulating hormone induced melanogenesis in melanoma B16 cells. Lee JH; Thanigaimalai P; Lee KC; Bang SC; Kim MS; Sharma VK; Yun CY; Roh E; Kim Y; Jung SH Chem Pharm Bull (Tokyo); 2010 Jul; 58(7):918-21. PubMed ID: 20606337 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of 3,4-dihydroquinazoline-2(1H)-thiones as inhibitors of alpha-MSH-induced melanin production in melanoma B16 cells. Thanigaimalai P; Lee KC; Bang SC; Lee JH; Yun CY; Roh E; Hwang BY; Kim Y; Jung SH Bioorg Med Chem; 2010 Feb; 18(4):1555-62. PubMed ID: 20097083 [TBL] [Abstract][Full Text] [Related]
5. Identification of indoline-2-thione analogs as novel potent inhibitors of α-melanocyte stimulating hormone induced melanogenesis. Thanigaimalai P; Lee KC; Sharma VK; Sharma N; Roh E; Kim Y; Jung SH Chem Pharm Bull (Tokyo); 2011; 59(10):1285-8. PubMed ID: 21963640 [TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship of naphthaldehydethiosemicarbazones in melanogenesis inhibition. Thanigaimalai P; Rao EV; Lee KC; Sharma VK; Roh E; Kim Y; Jung SH Bioorg Med Chem Lett; 2012 Jan; 22(2):886-9. PubMed ID: 22217872 [TBL] [Abstract][Full Text] [Related]
7. Piperlonguminine from Piper longum with inhibitory effects on alpha-melanocyte-stimulating hormone-induced melanogenesis in melanoma B16 cells. Min KR; Kim KS; Ro JS; Lee SH; Kim JA; Son JK; Kim Y Planta Med; 2004 Dec; 70(12):1115-8. PubMed ID: 15643542 [TBL] [Abstract][Full Text] [Related]
8. Ketonethiosemicarbazones: structure-activity relationships for their melanogenesis inhibition. Thanigaimalai P; Lee KC; Sharma VK; Roh E; Kim Y; Jung SH Bioorg Med Chem Lett; 2011 Jun; 21(12):3527-30. PubMed ID: 21601449 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of melanogenesis inhibition by 2,5-dimethyl-4-hydroxy-3(2H)-furanone. Lee J; Jung E; Lee J; Huh S; Boo YC; Hyun CG; Kim YS; Park D Br J Dermatol; 2007 Aug; 157(2):242-8. PubMed ID: 17650175 [TBL] [Abstract][Full Text] [Related]
10. Effect of pyrroloquinoline quinone (PQQ) on melanogenic protein expression in murine B16 melanoma. Sato K; Toriyama M J Dermatol Sci; 2009 Feb; 53(2):140-5. PubMed ID: 19013771 [TBL] [Abstract][Full Text] [Related]
12. Structural characteristics of thiosemicarbazones as inhibitors of melanogenesis. Lee KC; Thanigaimalai P; Sharma VK; Kim MS; Roh E; Hwang BY; Kim Y; Jung SH Bioorg Med Chem Lett; 2010 Nov; 20(22):6794-6. PubMed ID: 20863702 [TBL] [Abstract][Full Text] [Related]
13. Effect of Angelica gigas extract on melanogenesis in B16 melanoma cells. Lv N; Koo JH; Yoon HY; Yu J; Kim KA; Choi IW; Kwon KB; Kwon KS; Kim HU; Park JW; Park BH Int J Mol Med; 2007 Nov; 20(5):763-7. PubMed ID: 17912471 [TBL] [Abstract][Full Text] [Related]
14. Partially purified Curcuma longa inhibits alpha-melanocyte-stimulating hormone-stimulated melanogenesis through extracellular signal-regulated kinase or Akt activation-mediated signalling in B16F10 cells. Jang JY; Lee JH; Jeong SY; Chung KT; Choi YH; Choi BT Exp Dermatol; 2009 Aug; 18(8):689-94. PubMed ID: 19469902 [TBL] [Abstract][Full Text] [Related]
15. Regioselective synthesis of novel 4,5-diaryl functionalized 3,4-dihydropyrimidine-2(1H)-thiones via a non-Biginelli-type approach and evaluation of their in vitro anticancer activity. Sośnicki JG; Struk Ł; Kurzawski M; Perużyńska M; Maciejewska G; Droździk M Org Biomol Chem; 2014 Jun; 12(21):3427-40. PubMed ID: 24752551 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and docking studies of bischalcones based quinazoline-2(1H)-ones and quinazoline-2(1H)-thiones derivatives as novel inhibitors of cathepsin B and cathepsin H. Raghav N; Singh M Eur J Pharm Sci; 2014 Apr; 54():28-39. PubMed ID: 24412851 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of some 4-(1H-indol-3-yl)-6-phenyl-1,2,3,4-tetrahydropyrimidin-2-ones/thiones as potent anti-inflammatory agents. Amir M; Javed SA; Kumar H Acta Pharm; 2008 Dec; 58(4):467-77. PubMed ID: 19103580 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and QSAR studies on 5-[2-(2-methylprop1-enyl)-1H benzimidazol-1yl]-4,6-diphenyl-pyrimidin-2-(5H)-thione derivatives as antibacterial agents. Sharma P; Kumar A; Sharma M Eur J Med Chem; 2006 Jul; 41(7):833-40. PubMed ID: 16730396 [TBL] [Abstract][Full Text] [Related]
19. Structural requirement(s) of N-phenylthioureas and benzaldehyde thiosemicarbazones as inhibitors of melanogenesis in melanoma B 16 cells. Thanigaimalai P; Hoang TA; Lee KC; Bang SC; Sharma VK; Yun CY; Roh E; Hwang BY; Kim Y; Jung SH Bioorg Med Chem Lett; 2010 May; 20(9):2991-3. PubMed ID: 20359890 [TBL] [Abstract][Full Text] [Related]